查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946539

2026年全球微针药物输送系统市场报告

Microneedle Drug Delivery Systems Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，微针给药系统的市场规模迅速扩张，预计将从2025年的58.6亿美元成长到2026年的69.2亿美元，复合年增长率达18.1%。这一增长可能归功于经皮给药研究的进展、患者对微创疗法的偏好日益增强、疫苗接种计划的扩大、使用微针的临床试验增加以及微加工技术的进步。

预计未来几年，微针给药系统市场将快速成长，到2030年市场规模将达到131.6亿美元，复合年增长率（CAGR）为17.4%。预测期内的成长要素包括：自我护理医疗设备的日益普及、生物製药给药系统投资的增加、可穿戴给药平台的扩展、对患者依从性的日益重视以及微针产品的商业化程度不断提高。预测期内的主要趋势包括：可溶解微针技术的日益普及、对无痛给药方式的需求不断增长、对疫苗给药应用的日益重视、自我给药系统的扩展以及对可生物降解微针的日益重视。

预计未来几年，肥胖症的盛行率上升将推动微针给药系统市场的成长。肥胖症是一种以体内脂肪过度堆积为特征的疾病，会对整体健康造成不利影响。微针给药系统因其能为患者提供便捷无痛的给药方式，在肥胖症治疗中得到越来越广泛的应用。例如，根据英国政府机构－健康改善和消除不平等部发布的数据，2023年至2024年，英格兰18岁及以上成年人中约有64.5%被归类为超重或肥胖，高于2022年至2023年的64.0%。因此，肥胖症盛行率的上升正在促进微针给药系统市场的扩张。

为了提供客户可靠的服务，微针药物输送系统市场的主要企业正致力于产品创新，例如射频微针系统。射频微针系统是一种微创技术，它结合了微针和射频能源，可改善药物传输并促进皮肤胶原蛋白生成，从而达到治疗和美容的双重目的。例如，2023年2月，总部位于美国的医疗美容设备製造商Candela推出了Profound Matrix系统。此多功能係统包含Sublime、Sublative RF和尖端的Matrix 施用器。 Sublime和Sublative RF皆采用双极射频（RF）技术，可有效改善细纹和深层皱纹。同时，Matrix Pro治疗头旨在透过一系列细小的微针将短脉衝射频能量输送到皮肤，促进胶原蛋白再生和生成。这提高了患者的舒适度，减少了恢復时间，并改善了整体治疗效果。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球微针药物输送系统市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 永续性、气候技术和循环经济
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 溶解性微针技术的应用日益广泛
    • 无痛给药方式的需求日益增长
    • 更加重视疫苗接种应用
    • 自我给药系统的扩展
    • 人们对可生物降解微针的兴趣日益浓厚

第五章 终端用户产业市场分析

  • 医院
  • 门诊手术中心
  • 研究所
  • 诊断检查室
  • 生命科学公司

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球微针给药系统市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球微针药物输送系统市场规模、比较及成长率分析
  • 全球微针药物输送系统市场表现：规模与成长，2020-2025年
  • 全球微针药物输送系统市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 透过技术
  • 中空、多孔、固体及其他技术
  • 透过使用
  • 药物传输、疫苗传递及其他应用
  • 最终用户
  • 生命科学、实验室、医院、门诊手术中心和其他终端用户
  • 按类型细分：中空
  • 固体中空微针，涂层中空微针
  • 按类型细分：多孔材料
  • 多孔硅微针，水凝胶基多孔微针
  • 按类型细分：固体
  • 用于疫苗的固体微针，用于药物输送的固体微针
  • 按类型细分：其他技术
  • 可溶解微针，可生物降解微针

第十章 区域与国家分析

  • 全球微针药物输送系统市场：区域分析、预测（2020-2025年、2025-2030年预测、2035年预测）
  • 全球微针药物输送系统市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 微针药物输送系统市场：竞争格局及市场占有率（2024年）
  • 微针药物输送系统市场：公司估值矩阵
  • 微针给药系统市场：公司概况
    • Zosano Pharma Corporation
    • Nanopass Technologies
    • Raphas Co. Ltd.
    • Micron Biomedical Inc.
    • Vaxess Technologies

第37章：其他领先和创新企业

  • Debiotech, TheraJect Inc., Corium Inc., Valeritas Inc., LTS Lohmann Therapie-Systeme AG, Cutanos, Moonlight Therapeutics Inc., QuadMedicine, SNVIA Co. Ltd., NanoPass Technologies Ltd., BioSerenTach, Innoture Medical Technology Limited, AdminMed nanoBioSciences LLC, MyLife Technologies, Micropoint Technologies

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年微针药物输送系统市场：提供新机会的国家
  • 2030年微针药物输送系统市场：充满新机会的细分市场
  • 2030年微针药物输送系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MMDDS01_G26Q1

Microneedle Drug Delivery Systems are sophisticated medical devices that utilize arrays of micron-sized needles to deliver drugs, vaccines, and other therapeutic agents through the skin with minimal invasiveness. They penetrate the stratum corneum without reaching deeper nerve endings, thereby minimizing pain and discomfort.

The main types of technologies used in microneedle drug delivery systems include solid microneedle technology, hollow microneedle technology, dissolved microneedle technology, and others. In the solid microneedle method, peptides are dried onto the tips of a microneedle array, utilizing a coating of potent chemicals. These solid microneedles typically measure between 250 micrometers to 700 micrometers in length and are presented in patch form, allowing for storage at room temperature. Microneedle drug delivery systems find application in drug delivery, vaccine administration, and other therapeutic uses. They are employed in various settings such as diagnostic laboratories, life sciences, research laboratories, hospitals, ambulatory surgical centers, and other medical facilities.

Tariffs are influencing the microneedle drug delivery systems market by increasing costs of imported microfabrication equipment, specialty polymers, biocompatible materials, and precision manufacturing components. Pharmaceutical and device developers in North America and Europe are most affected due to reliance on imported high-precision inputs, while Asia-Pacific faces higher export-related costs. These tariffs are increasing development and scaling expenses. However, they are also encouraging local manufacturing capabilities, regional material sourcing, and innovation in cost-effective microneedle production processes.

The microneedle drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides microneedle drug delivery systems market statistics, including microneedle drug delivery systems industry global market size, regional shares, competitors with a microneedle drug delivery systems market share, detailed microneedle drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the microneedle drug delivery systems industry. This microneedle drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microneedle drug delivery systems market size has grown rapidly in recent years. It will grow from $5.86 billion in 2025 to $6.92 billion in 2026 at a compound annual growth rate (CAGR) of 18.1%. The growth in the historic period can be attributed to growth in transdermal drug delivery research, rising patient preference for minimally invasive therapies, expansion of vaccination programs, increased clinical trials using microneedles, advancements in microfabrication techniques.

The microneedle drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $13.16 billion in 2030 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to increasing adoption of self-care medical devices, rising investments in biologics delivery systems, expansion of wearable drug delivery platforms, growing focus on patient compliance, increasing commercialization of microneedle products. Major trends in the forecast period include increasing adoption of dissolving microneedle technologies, rising demand for painless drug delivery methods, growing focus on vaccine delivery applications, expansion of self-administered drug systems, enhanced emphasis on biodegradable microneedles.

The rising prevalence of obesity is anticipated to drive the growth of the microneedle drug delivery systems market in the coming years. Obesity is a medical condition defined by excessive accumulation of body fat that poses adverse risks to overall health. Microneedle drug delivery systems are increasingly utilized in obesity management as they enable the convenient and painless administration of medications to patients. For example, in May 2025, data from the Office for Health Improvement and Disparities, a United Kingdom-based government body, indicated that between 2023 and 2024, approximately 64.5% of adults aged 18 years and above in England were classified as overweight or living with obesity, compared to 64.0% during 2022 to 2023. Consequently, the growing prevalence of obesity is contributing to the expansion of the microneedle drug delivery systems market.

Major companies in the microneedle drug delivery systems market are concentrating on product innovation, such as radiofrequency microneedle systems, to deliver dependable services to their customers. A radiofrequency microneedle system is a minimally invasive technology that integrates microneedles with radiofrequency energy to improve drug delivery and stimulate collagen production in the skin for both therapeutic and cosmetic purposes. For example, in February 2023, Candela, a US-based medical aesthetic device manufacturer, introduced the Profound Matrix system. This multi-application system includes the Sublime, Sublative RF, and the cutting-edge Matrix Pro applicators. Both the Sublime and Sublative RF utilize bipolar radiofrequency (RF) technology to enhance the appearance of fine lines and wrinkles, while the Matrix Pro applicator is designed to regenerate and stimulate collagen production. It features a series of slender microneedles that deliver short-pulse RF energy to the skin, resulting in improved patient comfort, decreased downtime, and enhanced overall outcomes.

In October 2023, JW Pharmaceutical Corp., a South Korea-based pharmaceutical company, entered into a partnership with Theraject Asia Co., Ltd. to support the development of microneedle-based treatments for hair loss. Through this collaboration, JW Pharmaceutical and Theraject Asia seek to utilize Theraject Asia's microneedle technology platform to develop user-friendly and effective drug delivery solutions for hair loss by integrating advanced drug formulations with next-generation transdermal delivery approaches. Theraject Asia Co., Ltd. is a South Korea-based company focused on microneedle research and drug delivery technologies.

Major companies operating in the microneedle drug delivery systems market are Zosano Pharma Corporation, Nanopass Technologies, Raphas Co. Ltd., Micron Biomedical Inc., Vaxess Technologies, Debiotech, TheraJect Inc., Corium Inc., Valeritas Inc., LTS Lohmann Therapie-Systeme AG, Cutanos, Moonlight Therapeutics Inc., QuadMedicine, SNVIA Co. Ltd., NanoPass Technologies Ltd., BioSerenTach, Innoture Medical Technology Limited, AdminMed nanoBioSciences LLC, MyLife Technologies, Micropoint Technologies

North America was the largest region in the microneedle drug delivery systems market in 2025. Europe was the second-largest region in the microneedle drug delivery systems market analysis. The regions covered in the microneedle drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the microneedle drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The microneedle drug delivery systems market consists of sales of hydrogel microneedles and dissolvable microneedle. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microneedle Drug Delivery Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses microneedle drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microneedle drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microneedle drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Technology: Hollow; Porous; Solid; Other Technologies
  • 2) By Application: Drug Delivery; Vaccine Delivery; Other Applications
  • 3) By End-User: Life Sciences; Research Laboratories; Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Hollow: Solid Hollow Microneedles; Coated Hollow Microneedles
  • 2) By Porous: Porous Silicon Microneedles; Hydrogel-Based Porous Microneedles
  • 3) By Solid: Solid Microneedles For Vaccination; Solid Microneedles For Drug Delivery
  • 4) By Other Technologies: Dissolving Microneedles; Biodegradable Microneedles
  • Companies Mentioned: Zosano Pharma Corporation; Nanopass Technologies; Raphas Co. Ltd.; Micron Biomedical Inc.; Vaxess Technologies; Debiotech; TheraJect Inc.; Corium Inc.; Valeritas Inc.; LTS Lohmann Therapie-Systeme AG; Cutanos; Moonlight Therapeutics Inc.; QuadMedicine; SNVIA Co. Ltd.; NanoPass Technologies Ltd.; BioSerenTach; Innoture Medical Technology Limited; AdminMed nanoBioSciences LLC; MyLife Technologies; Micropoint Technologies
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Microneedle Drug Delivery Systems Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Microneedle Drug Delivery Systems Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Microneedle Drug Delivery Systems Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Microneedle Drug Delivery Systems Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Sustainability, Climate Tech & Circular Economy
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Dissolving Microneedle Technologies
    • 4.2.2 Rising Demand For Painless Drug Delivery Methods
    • 4.2.3 Growing Focus On Vaccine Delivery Applications
    • 4.2.4 Expansion Of Self-Administered Drug Systems
    • 4.2.5 Enhanced Emphasis On Biodegradable Microneedles

5. Microneedle Drug Delivery Systems Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Research Laboratories
  • 5.4 Diagnostics Laboratories
  • 5.5 Life Sciences Companies

6. Microneedle Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Microneedle Drug Delivery Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Microneedle Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Microneedle Drug Delivery Systems Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Microneedle Drug Delivery Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Microneedle Drug Delivery Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Microneedle Drug Delivery Systems Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Microneedle Drug Delivery Systems Market Segmentation

  • 9.1. Global Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hollow, Porous, Solid, Other Technologies
  • 9.2. Global Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Delivery, Vaccine Delivery, Other Applications
  • 9.3. Global Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Life Sciences, Research Laboratories, Hospitals, Ambulatory Surgical Centers, Other End-Users
  • 9.4. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Hollow, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Solid Hollow Microneedles, Coated Hollow Microneedles
  • 9.5. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Porous, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Porous Silicon Microneedles, Hydrogel-Based Porous Microneedles
  • 9.6. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Solid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Solid Microneedles For Vaccination, Solid Microneedles For Drug Delivery
  • 9.7. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Dissolving Microneedles, Biodegradable Microneedles

10. Microneedle Drug Delivery Systems Market Regional And Country Analysis

  • 10.1. Global Microneedle Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Microneedle Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Microneedle Drug Delivery Systems Market

  • 11.1. Asia-Pacific Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Microneedle Drug Delivery Systems Market

  • 12.1. China Microneedle Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Microneedle Drug Delivery Systems Market

  • 13.1. India Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Microneedle Drug Delivery Systems Market

  • 14.1. Japan Microneedle Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Microneedle Drug Delivery Systems Market

  • 15.1. Australia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Microneedle Drug Delivery Systems Market

  • 16.1. Indonesia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Microneedle Drug Delivery Systems Market

  • 17.1. South Korea Microneedle Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Microneedle Drug Delivery Systems Market

  • 18.1. Taiwan Microneedle Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Microneedle Drug Delivery Systems Market

  • 19.1. South East Asia Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Microneedle Drug Delivery Systems Market

  • 20.1. Western Europe Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Microneedle Drug Delivery Systems Market

  • 21.1. UK Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Microneedle Drug Delivery Systems Market

  • 22.1. Germany Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Microneedle Drug Delivery Systems Market

  • 23.1. France Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Microneedle Drug Delivery Systems Market

  • 24.1. Italy Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Microneedle Drug Delivery Systems Market

  • 25.1. Spain Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Microneedle Drug Delivery Systems Market

  • 26.1. Eastern Europe Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Microneedle Drug Delivery Systems Market

  • 27.1. Russia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Microneedle Drug Delivery Systems Market

  • 28.1. North America Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Microneedle Drug Delivery Systems Market

  • 29.1. USA Microneedle Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Microneedle Drug Delivery Systems Market

  • 30.1. Canada Microneedle Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Microneedle Drug Delivery Systems Market

  • 31.1. South America Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Microneedle Drug Delivery Systems Market

  • 32.1. Brazil Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Microneedle Drug Delivery Systems Market

  • 33.1. Middle East Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Microneedle Drug Delivery Systems Market

  • 34.1. Africa Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Microneedle Drug Delivery Systems Market Regulatory and Investment Landscape

36. Microneedle Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 36.1. Microneedle Drug Delivery Systems Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Microneedle Drug Delivery Systems Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Microneedle Drug Delivery Systems Market Company Profiles
    • 36.3.1. Zosano Pharma Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Nanopass Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Raphas Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Micron Biomedical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Vaxess Technologies Overview, Products and Services, Strategy and Financial Analysis

37. Microneedle Drug Delivery Systems Market Other Major And Innovative Companies

  • Debiotech, TheraJect Inc., Corium Inc., Valeritas Inc., LTS Lohmann Therapie-Systeme AG, Cutanos, Moonlight Therapeutics Inc., QuadMedicine, SNVIA Co. Ltd., NanoPass Technologies Ltd., BioSerenTach, Innoture Medical Technology Limited, AdminMed nanoBioSciences LLC, MyLife Technologies, Micropoint Technologies

38. Global Microneedle Drug Delivery Systems Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Microneedle Drug Delivery Systems Market

40. Microneedle Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 40.1 Microneedle Drug Delivery Systems Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Microneedle Drug Delivery Systems Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Microneedle Drug Delivery Systems Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer